Satish Appalakutty

Last updated: February 10, 2026

ChapmanAlbin is reviewing potential investor claims involving Satish Appalakutty and his business entities Lorven Funds and Lorven Advisors LLC. On January 29, 2026, the Securities and Exchange Commission announced charges alleging a Ponzi-like scheme that raised at least $37 million from at least 100 investors. See the SEC’s release: Litigation Release No. 26472.

The SEC alleges investor funds were solicited for multiple purported investment opportunities, including promissory-note style investments promising high, guaranteed returns. If you invested with Appalakutty or the Lorven entities, you may have legal options to pursue recovery.

Key facts at a glance

• SEC case: Securities and Exchange Commission v. Satish Appalakutty, et al., No. 3:26-cv-00917 (N.D. Cal. filed Jan. 29, 2026).
• Time period alleged: at least the beginning of 2019 through March 2024.
• Amounts alleged: at least $37 million raised from at least 100 investors.
• Core allegation: Ponzi-like scheme using new investor money to pay prior investors, with funds also allegedly misappropriated for personal use and to fund a software startup, Vistalytics Inc.

What the SEC alleges

According to the SEC complaint, Appalakutty and the Lorven entities offered three types of purported investment opportunities: (1) “secondary public offering” or SPO transactions to buy discounted public-company shares; (2) purchases of shares in private pre-IPO companies; and (3) high-interest “debt” or promissory note investments not tied to any specific security. The SEC alleges these opportunities were fictional and that no such stock purchases or other income-generating activities were conducted on investors’ behalf.

The SEC alleges the pitches often included promises of exceptionally high, guaranteed returns, ranging from 8% to 62.5% annualized, and assurances that investors would not lose principal.

How the SEC says investor money was used

• In Ponzi-like fashion, new investor funds were allegedly used to make payments to prior investors to create the appearance of legitimate returns.
• The SEC alleges approximately $6.7 million was misappropriated for Appalakutty’s personal benefit, including personal residence-related spending, vehicles, and travel.
• The SEC alleges approximately $4.4 million of investor funds was used to fund and pay expenses for Vistalytics Inc., a software startup associated with Appalakutty.

The complaint also alleges investors were sometimes encouraged to “roll over” principal and purported returns into new investments, and that fabricated account statements were provided when investors asked about investment status.

Why promissory notes and “guaranteed returns” can be red flags

Promissory notes are not automatically fraudulent, but in many investor-loss cases they appear when the investment is private, promises unusually high returns, and is not reflected in a traditional brokerage account statement. If you were offered a promissory note or a private “debt” deal, you may find these resources helpful:

• Promissory Note Fraud
• Is My Promissory Note a Scam? Red Flags to Look For
• Promissory Note Fraud Overview

For additional information about Ponzi schemes and common warning signs, see:

• Ponzi Schemes

What to do if you invested with Satish Appalakutty or the Lorven entities

1. Gather documents: promissory notes, agreements, wire confirmations, canceled checks, emails, texts, and any account summaries or “statements” provided to you.
2. Write down a timeline: dates invested, amounts invested, promised returns, payments received, and when payments stopped.
3. Request banking and transfer records from your financial institution(s) for any wires, ACH transfers, or checks related to the investment.
4. Do not sign releases or accept a proposed resolution without legal review.

Speak with ChapmanAlbin

If you invested with Satish Appalakutty, Lorven Funds, or Lorven Advisors LLC and have concerns about promissory notes, private “debt” deals, pre-IPO offerings, or potential misappropriation, ChapmanAlbin can evaluate your situation and discuss potential options.

Call ChapmanAlbin at (877) 410-8172 for a free, confidential consultation.